Calithera Biosciences is a clinical-stage biopharmaceutical company pioneering the discovery and development of targeted therapies that disrupt cellular metabolic pathways to preferentially starve tumor cells and enhance immune-cell activity. Driven by a commitment to rigorous science and a passion for improving the lives of people impacted by cancer and other life-threatening diseases, Calithera is advancing a pipeline of first-in-clinic, oral therapeutics to meaningfully expand treatment options available to patients.
Location: United States, California, South San Francisco
Employees: 51-200
Total raised: $77.4M
Founded date: 2010
Investors 4
| Date | Name | Website |
| - | Mission Bi... | missionbio... |
| - | Lightstone... | lightstone... |
| - | Delphi Ven... | delphivent... |
| - | New Leaf V... | nlvpartner... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 02.11.2020 | - | $2.4M | - |
| 29.10.2013 | Series D | $35M | - |
| 08.07.2010 | Series A | $40M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 29.03.2022 | Calithera Biosciences, Inc. Announces Commencement of Underw... | SOUTH SAN FRANCISCO, Calif., March 29, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq:... | globenewsw... |
| 18.10.2021 | Calithera Biosciences : Investor Deck | Targeting cancer, differently. Susan M. Molineaux, Ph.D. | Founder, President & Chief Executive... | marketscre... |
| 17.05.2021 | Antengene and Calithera Biosciences Enter into Worldwide Exc... | SHANGHAI and SOUTH SAN FRANCISCO, Calif., May 17, 2021 /PRNewswire/ -- Antengene Corporation Limited... | en.prnasia... |
| 02.11.2020 | Calithera Biosciences receives a $2.4M funding award from th... | Calithera Biosciences is a San Francisco-based clinical-stage biopharmaceutical company pioneering t... | techstartu... |
| 29.06.2016 | The biotech IPO feast flags as investors lose their appeti... | There was a time after the 2008 crash that biotech IPOs were about as popular as snow in March. B... | endpts.com... |
| 29.10.2013 | Calithera Biosciences Secures $35Min Series D | SOUTH SAN FRANCISCO, CA, Biotechnology company focused on the development of novel cancer therapeu... | vcnewsdail... |
| 29.10.2013 | Calithera Biosciences Completes $35M Series D Financing | Calithera Biosciences, a South San Francisco, CA-based biotechnology company focused on the developm... | finsmes.co... |
| 29.10.2013 | UPDATED: Calithera grabs $35M round to fund first slate of c... | Calithera Biosciences CEO Susan Molineaux South San Francisco-based Calithera Biosciences has lande... | fiercebiot... |
| 08.07.2010 | Calithera Biosciences Completes $40M Series A Financing | Calithera Biosciences, a South San Francisco, CA-based developer of innovative oncology therapeutics... | finsmes.co... |